(ABUS) Arbutus Biopharma - Performance 9.9% in 12m
Compare ABUS with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
22.43%
#20 in Group
Rel. Strength
83.77%
#1292 in Universe
Total Return 12m
9.86%
#31 in Group
Total Return 5y
124.31%
#10 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -11.49%
(?) Percentile in Group
12m Total Return: ABUS (9.9%) vs XBI (-14%)
5y Drawdown (Underwater) Chart
Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| UTHR NASDAQ United Therapeutics |
2.95% | 13.3% | 161% | 12.1 | 11 | 1.43 | 74.6% | 16.1% |
| HLN NYSE Haleon |
12.6% | 32.2% | 49.3% | 24.4 | 20.2 | 1.79 | 69.1% | 13.6% |
| AMGN NASDAQ Amgen |
-8.67% | -12.4% | 27.7% | 25.5 | 13.5 | 0.95 | 0.60% | 41% |
| LONN SW Lonza |
15.8% | 12% | 33.5% | 67.1 | 35.1 | 1.28 | 2.20% | -12.5% |
| BIM PA Biomerieux |
4.68% | 18.2% | -1.63% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
| KMDA NASDAQ Kamada |
14.1% | 27.3% | -5.64% | 26.6 | 23.9 | 0.96 | 32.5% | 3.93% |
| NBIX NASDAQ Neurocrine Biosciences |
21.4% | -17.2% | 1.88% | 32.3 | 21.6 | 0.27 | 68.0% | 31.9% |
| ERF PA Eurofins Scientific SE |
22.4% | 0.59% | 8.05% | 26.6 | 13.6 | 0.56 | -66.6% | -17.1% |
Performance Comparison: ABUS vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ABUS
| Total Return (including Dividends) | ABUS | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 1.89% | 2.02% | 2.87% |
| 3 Months | -3.00% | -15.44% | -6.42% |
| 12 Months | 9.86% | -14.02% | 9.87% |
| 5 Years | 124.31% | -26.47% | 107.51% |
| Trend Score (consistency of price movement) | ABUS | XBI | S&P 500 |
| 1 Month | 67.3% | 57% | 89.4% |
| 3 Months | -14.3% | -82.3% | -72% |
| 12 Months | -16.1% | -53.1% | 49.3% |
| 5 Years | -1.50% | -53.9% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
| 1 Month | #106 | -0.12% | -0.95% |
| 3 Month | #34 | 14.7% | 3.65% |
| 12 Month | #31 | 27.8% | -0.01% |
| 5 Years | #10 | 205% | 8.09% |
FAQs
Does ABUS Arbutus Biopharma outperforms the market?
Yes,
over the last 12 months ABUS made 9.86%, while its related Sector, the SPDR S&P Biotech (XBI) made -14.02%.
Over the last 3 months ABUS made -3.00%, while XBI made -15.44%.
Over the last 3 months ABUS made -3.00%, while XBI made -15.44%.
Performance Comparison ABUS vs Indeces and Sectors
ABUS vs. Indices ABUS is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -9.60% | -0.98% | -8.25% | -0.01% |
| US NASDAQ 100 | QQQ | -9.85% | -2.82% | -8.66% | -1.46% |
| US Dow Jones Industrial 30 | DIA | -9.88% | 0.28% | -7.22% | 3.49% |
| German DAX 40 | DAX | -11.7% | -17.4% | -33.8% | -15.2% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -10.3% | -4.38% | -7.48% | 4.23% |
| Hongkong Hang Seng | HSI | -13.1% | -14.3% | -17.7% | -2.23% |
| India NIFTY 50 | INDA | -7.21% | -0.39% | -10.2% | 7.53% |
| Brasil Bovespa | EWZ | -11.7% | -9.64% | -17.5% | 16.3% |
ABUS vs. Sectors ABUS is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -9.78% | -1.78% | -14.4% | -10.5% |
| Consumer Discretionary | XLY | -10.5% | -1.62% | -6.06% | -4.19% |
| Consumer Staples | XLP | -9.23% | -0.13% | -15.2% | 2.30% |
| Energy | XLE | -10.6% | 1.81% | -2.25% | 19.6% |
| Financial | XLF | -10.2% | -3.68% | -14.1% | -11.7% |
| Health Care | XLV | -5.81% | 6.27% | -3.02% | 15.8% |
| Industrial | XLI | -11.2% | -5.49% | -9.23% | -0.13% |
| Materials | XLB | -9.59% | -2.82% | -4.20% | 15.9% |
| Real Estate | XLRE | -9.27% | -4.23% | -10.6% | -3.60% |
| Technology | XLK | -10.5% | -4.85% | -5.98% | 2.86% |
| Utilities | XLU | -10.6% | -3.73% | -16.0% | -6.05% |
| Aerospace & Defense | XAR | -10.1% | -7.45% | -17.6% | -15.3% |
| Biotech | XBI | -1.52% | -0.13% | 12.8% | 23.9% |
| Homebuilder | XHB | -9.16% | -1.18% | 5.38% | 19.6% |
| Retail | XRT | -9.75% | -1.70% | -1.96% | 14.2% |